Hemogenyx Pharmaceuticals PLC
LSE:HEMO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hemogenyx Pharmaceuticals PLC
LSE:HEMO
|
UK |
|
S
|
Smartoptics Group AS
OSE:SMOP
|
NO |
|
I
|
I Power Solutions India Ltd
BSE:512405
|
IN |
|
Jooyon Tech Co Ltd
KRX:044380
|
KR |
|
Sakai Holdings Co Ltd
TSE:9446
|
JP |
|
Septeni Holdings Co Ltd
TSE:4293
|
JP |
|
Orora Ltd
ASX:ORA
|
AU |
|
A
|
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
|
IN |
|
Mallee Resources Ltd
ASX:MYL
|
AU |
|
Westell Technologies Inc
OTC:WSTL
|
US |
|
S
|
Sky Gold Ltd
NSE:SKYGOLD
|
IN |
|
O
|
Ogunsen AB (publ)
STO:OGUN B
|
SE |
|
Becton Dickinson and Co
NYSE:BDX
|
US |
|
Curtis Banks Group PLC
LSE:CBP
|
UK |
Bankruptcy Probability
Hemogenyx Pharmaceuticals PLC's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hemogenyx Pharmaceuticals PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Hemogenyx Pharmaceuticals PLC
LSE:HEMO
|
61.5m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
362.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hemogenyx Pharmaceuticals PLC's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hemogenyx Pharmaceuticals PLC has total debt of 1.8m GBP. This includes both short-term (0 GBP) and long-term (1.8m GBP) debt.
You can find a full breakdown on its Balance Sheet.
